Clinical trial Recruiting at 5 sites Interventional Ages 18 to 59

Can seven tasks help distinguish schizophrenia and schizoaffective disorder from healthy people

Official title: Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium

Run by Washington University School of Medicine · NCT07853807 · Data updated 2026-11-12

The study tests seven cognitive tasks to see if they can tell apart people with schizophrenia or schizoaffective disorder from healthy adults and predict symptoms like hallucinations and delusions.

Quick facts

Study typeInterventional
Ages18 Years to 59 Years
SexAll
Enrollment325 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations5 sites (Irvine, California and 4 other locations)
StatusRecruiting
StartedNovember 15, 2026
Main results expectedJune 30, 2031
Study endsJune 30, 2031
Registry record updatedNovember 9, 2026
Trial IDNCT07853807 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-59 with schizophrenia or schizoaffective disorder or healthy controls matched on age and demographics.

Probably not a fit

Individuals with recent substance use disorders, significant head injury, or neurological disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Study 1 will have participants complete seven tasks across four sessions with EEG recording to compare their performance across diagnostic groups. Researchers will examine how task-based models relate to clinical measures of hallucinations and delusions, and whether these model parameters offer advantages over standard behavioral methods. The project also probes whether hallucinations and delusions arise from shared or separate underlying processes and whether task-based metrics improve prediction of psychotic symptoms. Participants will undergo comprehensive clinical interviews, self-report assessments, and neurocognitive testing to characterize function and symptoms. The study will recruit adults with schizophrenia or schizoaffective disorder and matched healthy controls, and will analyze psychometric properties and variance explained by the tasks.

Why it matters

Potential benefit: If successful, the tasks could provide more precise tools for diagnosing and predicting symptom trajectories in psychotic disorders.

How similar studies have gone: Previous work has shown that cognitive and EEG-based tasks can differentiate psychotic disorders from controls, though this specific multi-task, model-based approach is being tested for added precision.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

General Inclusion

1. age 18 to 59
2. no substance disorder in past six months (confirmed with urine drug screens and breathalyzers);
3. no clinically significant head injury or neurological disease. 4. Wechsler Test of Adult Reading (WTAR) score =16+.

Group Specific Criteria: Schizophrenia/Schizoaffective Disorder (SZ):

1. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnosis of schizophrenia or schizoaffective;
2. no medication changes in prior month or anticipated in the next month or not taking medications
3. outpatient or partial hospital if unmedicated

Healthy Controls (HC):

1. no Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder;
2. no family history of psychosis or bipolar

Exclusion Criteria:

Healthy Controls (HC):

1. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder diagnosis
2. Family history of psychosis or bipolar

Schizophrenia/Schizoaffective Disorder (SZ/SZA): additional exclusion criteria for the unmedicated individuals are:

1. not in acute exacerbation requiring immediate hospitalization or treatment
2. self-reported medication non-compliance for at least the four previous weeks 3)never having started medications

Where it's running

  • University of California, Irvine
    Irvine, California, United States
    Recruiting
  • The University of Chicago
    Chicago, Illinois, United States
    Recruiting
  • University of Maryland, Baltimore
    Baltimore, Maryland, United States
    Recruiting
  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting
  • Washington University
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Deanna Barch, Ph.D. — Washington University School of Medicine
  • Study coordinator: Deanna Barch, Ph.D.
  • Email: dbarch@wustl.edu
  • Phone: 314-935-8729

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.